ACTAVIS
FDA Approves Unknown Drug — ACTAVIS ELIZABETH
Sanofi has announced that its subsidiary, Actavis Elizabeth, has received final approval from the FDA for its generic drug, which is expected to竞争扩大该产...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Novartis
FDA Approves COSENTYX — Novartis Pharmaceuticals Corporation
Novartis Pharmaceuticals received FDA approval for Secukinumab (Cosentyx) on Jan. 21, 2015, a strategic milestone expected to bolster the company’s po...
Zydus
FDA Approves CARBIDOPA AND LEVODOPA — Zydus Pharmaceuticals USA Inc.
Zydus Pharmaceuticals USA Inc. secured FDA approval for Carbidopa and Levodopa, providing a new oral generic option into the high-volume central nervo...
TEVA
FDA Approves Unknown Drug — TEVA PHARMS USA
Teva Pharmaceutical received FDA approval for its Abbreviated New Drug Application (ANDA 202718) on December 29, 2014, enabling the generic launch of ...
E.R.
FDA Approves OPDIVO — E.R. Squibb & Sons, L.L.C.
The FDA has approved Opdivo (nivolumab) from E.R. Squibb & Sons, L.L.C., a key asset for the manufacturer's oncology franchise that is poised to bolst...
Carwin
FDA Approves POKONZA POTASSIUM CHLORIDE — Carwin Pharmaceutical Associates, LLC
Carwin Pharmaceutical Associates, LLC received FDA clearance for its potassium chloride oral formulation POKONZA, a move expected to expand generic su...
Merck
FDA Approves ZERBAXA — Merck Sharp & Dohme LLC
# FDA Approves Merck's ZERBAXA (Ceftolozane and Tazobactam) for Serious Bacterial Infections The FDA has approved Merck Sharp & Dohme LLC's ZERBAXA (...
PH
FDA Approves Unknown Drug — PH HEALTH
PH HEALTH has attained FDA approval under ANDA203573, a milestone finalized on December 18 that is anticipated to drive commercial growth and solidify...
Fonseca
FDA Approves XTORO — Fonseca Biosciences, LLC
# FDA Approves Fonseca Biosciences' XTORO for Ear Infections The FDA has approved Fonseca Biosciences' XTORO (finafloxacin), an otic fluoroquinolone ...
Epic
FDA Approves OXYMORPHONE HYDROCHLORIDE — Epic Pharma, LLC
Epic Pharma, LLC received FDA approval for its Abbreviated New Drug Application covering oral Oxymorphone Hydrochloride tablets, positioning the compa...
TEVA
FDA Approves Unknown Drug — TEVA PHARMS USA
Teva Pharmaceuticals USA has received approval for Nifedipine Extended-Release, a decision expected to intensify generic competition in the cardiovasc...
Eli
FDA Approves TRULICITY — Eli Lilly and Company
# FDA Approves Eli Lilly's Trulicity for Type 2 Diabetes Treatment Eli Lilly and Company received FDA approval for Trulicity (dulaglutide), a once-we...
Rhodes
FDA Approves OXYCODONE AND ACETAMINOPHEN — Rhodes Pharmaceuticals LLC
Rhodes Pharmaceuticals announced on August 28, 2014, that it received FDA approval for ANDA 201278, launching a generic version of the potent opioid c...
RISING
FDA Approves Unknown Drug — RISING
# FDA Approves Rising Pharmaceuticals' Generic Drug Application Rising Pharmaceuticals received FDA approval for an abbreviated new drug application ...
Hikma
FDA Approves BUPRENORPHINE AND NALOXONE — Hikma Pharmaceuticals USA Inc.
Hikma Pharmaceuticals USA Inc. announced the approval of its buprenorphine and naloxone sublingual product, strengthening the company’s presence in th...
Lannett
FDA Approves CODEINE SULFATE — Lannett Company, Inc.
Lannett Company, Inc. announced the approval of its Abbreviated New Drug Application (ANDA 203046) for generic codeine sulfate tablets, positioning th...
Amneal
FDA Approves OXYCODONE HYDROCHLORIDE — Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals secured FDA approval for the generic formulation of oxycodone hydrochloride, positioning the company to act as a price suppress...
Takeda
FDA Approves ENTYVIO — Takeda Pharmaceuticals America, Inc.
# FDA Approves Takeda's ENTYVIO for Inflammatory Bowel Disease Takeda Pharmaceuticals America, Inc. received FDA approval for ENTYVIO (vedolizumab), ...
ACTAVIS
FDA Approves Unknown Drug — ACTAVIS LABS FL INC
**ACTAVIS LABS FL INC** has announced that the FDA has approved **[Substance]** under ANDA **202144**. The approval is expected to immediately bolster...
Solco
FDA Approves IRBESARTAN AND HYDROCHLOROTHIAZIDE — Solco Healthcare US, LLC
# FDA Approves Generic Irbesartan and Hydrochlorothiazide from Solco Healthcare Solco Healthcare US, LLC has received FDA approval for a generic form...